Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2173 participants.
Also called NCT02601157
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,173 participants
- Registry
-
NCT02601157
-
- Other papers using this trial's data
- Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
- Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02601157. Randomized; no masking; primary purpose treatment. Start 2016-01-18 (registry gives no type); primary completion 2021-08-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
- Acronym
- HOST-IDEA
- Condition
- Stable Angina
- Condition
- Unstable Angina
- Condition
- Non-ST Segment Elevation Myocardial Infarction
- Intervention (Drug)
- 3-months DAPT
- Intervention (Drug)
- 1-year DAPT
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- B. Braun Korea Co., Ltd.
Record details
- Record id
cardio:ct-nct02601157- Content hash
97ebfeeac5de9d438cb3ae42d114f2bb437d02f77b224b2e3580f9c6c68c5c6e